Clinical trial Recruiting at 1 site Observational Ages Any age to 17

Modeling blood flow in children's brains after ECMO treatment

Official title: Cerebral Hemodynamic Impact in Children Depending on the Technique of Carotid Artery Decanulation Technique After Extracorporeal Membrane Oxygenation: Modeling of Intra-cerebral Vascular Flows

Run by Assistance Publique - Hôpitaux de Paris · NCT05237232 · Data updated 2026-11-12

This study looks at how two different methods for removing ECMO affect blood flow in the brains of young children who weigh less than 20 kg.

Quick facts

Study typeObservational
AgesAny age to 17 Years
SexAll
Enrollment30 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedMarch 31, 2022
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedSeptember 12, 2025
Trial IDNCT05237232 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include newborns, infants, and children under 20 kg who have undergone ECMO and are hospitalized in a pediatric intensive care unit.

Probably not a fit

Patients who are contraindicated for Magnetic Resonance Angiography or whose guardians oppose participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effects of extracorporeal membrane oxygenation (ECMO) on cerebral blood flow in children weighing less than 20 kg. It focuses on comparing hemodynamics based on two techniques used for carotid decanulation: reconstruction and ligation. Using Magnetic Resonance Angiography (MRA) and computational modeling, the study aims to provide insights into how these techniques impact arterial circulation and flow dynamics within the circle of Willis. The research is conducted at the pediatric and neonatal intensive care unit of Trousseau Hospital in Paris.

Why it matters

Potential benefit: If successful, this study could enhance understanding of cerebral blood flow dynamics in children post-ECMO, potentially improving surgical techniques and patient outcomes.

How similar studies have gone: While studies on ECMO exist, this specific modeling approach in pediatric patients is relatively novel and has limited prior research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For everyone :

1. Information and non-opposition of holders of parental authority
2. Newborn, infant and child \<20kg
3. Hospitalization in pediatric and neonatal intensive care unit (PICU) of Trousseau Hospital
4. Performing a Magnetic Resonance Angiography (MRA) as part of the treatment

   For patients treated with ECMO: study population
5. Hemodynamic or respiratory failure
6. Requiring the use of extracorporeal circulation with jugulo-carotid cannulation
7. Weaned alive off Extra corporeal membrane oxygenation (ECMO)

   For patients with hypoxic-ischemic encephalopathy: control population
8. hypoxic-ischemic encephalopathy diagnosed at birth

Exclusion Criteria:

1. Contraindication to MRA
2. Opposition of holders of parental authority

Where it's running

  • Hôpital Trousseau
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Sabine Irtan, MD, PhD — Assistance Publique - Hôpitaux de Paris
  • Study coordinator: Sabine Irtan, MD, PhD
  • Email: sabine.irtan@aphp.fr
  • Phone: 1 71 73 87 98

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.